Adeona Pharmaceuticals

About himAdeona Pharmaceuticals, Inc., founder and director Steve Kanzer has co founded, financed, and managed a number of biopharmaceutical companies that have successfully transitioned university based research into successful drug candidates. Mr. Kanzer served as co nike air max 90 founder and Chairman of Discovery Laboratories, Inc., the company that developed a clinical stage synthetic lung surfactant air max noir for infants who suffer from respiratory difficulties.

Steve H. Kanzer was also co founder and President of PolaRx Biopharmaceuticals, Inc., a start up that developed TRISENOX (arsenic trioxide), a leukemia drug. TRISENOX set a new, unbroken Food and Drug Administration record of 30 months for completing the process that begins with investigational new drug (IND) filing and concludes with new air max nike drug application (NDA) approval. In 2002, Steve Kanzer co founded Avigen, Inc., a gene medicine company that pioneered the use adeno associated air max pas cher virus (or « AAV ») vectors to develop gene based medications, now an industry standard in the gene medicine field.

Mr. Kanzer air max 90 has also co nike air max 2013 founded two biotech investment firms, Accredited Equities, Inc., and Accredited Ventures, Inc. A certified nike air max pas cher public accountant, Steve Kanzer possesses a Juris Doctor from the New York University School of Law and a Bachelor of Business Administration from Baruch College.